Yidao Biotechnology

About:

Yidao Biotechnology research and develops vaccines and biomedical products.

Website: https://www.immune-path.com

Top Investors: Qiming Venture Partners, Northern Light Venture Capital

Description:

Yidao Biotechnology research and develops vaccines and biomedical products. It focuses on the research and development of a variety of vaccines such as recombinant protein antigen vaccine, new virus vector vaccine, messenger RNA vaccine, and vaccine adjuvant platforms, providing vaccines to meet the needs of human health in both domestic and international markets. The Suzhou, Jiangsu-based biotech company was established in 2017.